钱维军文章提出蛋白质组学研究难点

【字体: 时间:2006年12月21日 来源:生物通

编辑推荐:

  来自美国能源部西北太平洋国家实验室PNNL(Pacific Northwest National Laboratory)的研究人员提出了蛋白质组学研究在临床应用中液相层析技术中的关键点和难点,并将这一研究成果公布在《Molecular & Cellular Proteomics》(MCP)杂志上。

  

生物通报道:来自美国能源部西北太平洋国家实验室PNNL(Pacific Northwest National Laboratory)的研究人员提出了蛋白质组学研究在临床应用中液相层析技术中的关键点和难点,并将这一研究成果公布在《Molecular & Cellular Proteomics》(MCP)杂志上。

文章的第一作者是来自PNNL的钱维军博士(Wei-jun Qian,音译)。

原文摘要:
Molecular & Cellular Proteomics 5:1727-1744, 2006.
Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications
[Abstract]

人们常说“血浓于水”,除了说明家族之间关系的密切性以外,这个习语也告诉我们,血液是由不同蛋白和其它成份组成的复杂复合物,这构成了我们人类的差异性,但也给研究人员带来了极大的分离困难。

血液用于评价一个人的健康状况已经由来已久了,这是由于不像其它细胞或者组织,血液可以方便的取得,而且几乎包含了身体内所有的蛋白,但是在这篇文章中,研究人员提出“重要蛋白实际上存在的浓度是极其低的”,因此现在已经需要重新考虑血液在蛋白分析方面的作用了。

研究报告提到“利用蛋白组学方法是否可以精确的检测和辨认血浆中疾病的生物标记(biomarkers)?”这也导致研究人员对其它研究对象的怀疑,比如脑脊髓液,支气管肺泡灌洗液(bronchoalveolar lavage fluid),生理滑液,乳头吸取液(nipple aspirate fluid),唾液,尿液,以及肿瘤间质液体(tumor interstitial fluids)。

正如那篇文章中提及的,“血液大部分是由几种非常高浓度的蛋白组成——22种高丰度蛋白代表了血浆中总蛋白量的99%”,所以无论分析的是血清还是粘液,低丰度蛋白也许都无法被检测到。而且血浆中蛋白集合的蛋白浓度是在一个高动态范围内((>10 orders of magnitude)变动——从45 mg/ml的血清白蛋白,到1–10 pg/ml或更低的趋化因子。除此之外还有翻译后修饰的可变性,拼接,以及人类遗传变异和蛋白分离影响。
(生物通:张迪)

附:
美国能源部:西北太平洋国家实验室PNNL(Pacific Northwest National Laboratory) 

【URL】 http://www.pnl.gov/

【简介】The Pacific Northwest National Laboratory is one of nine U.S. Department of Energy multiprogram national laboratories. 

Battelle has operated Pacific Northwest for DOE and its predecessors since 1965. 

Pacific Northwest National Laboratory's history began in 1965 when Battelle won the contract to perform research and development for the Hanford Site, a nuclear site in southeastern Washington State. The Laboratory's first projects were based on the needs of the Hanford Site and included protecting the environment, fabricating reactor fuel, and designing reactors. These projects, staff expertise in diverse fields, and national needs led to outstanding research and development in several key areas: environment, health, energy, computer science, and security. 

Business Statistics (2002)

Business Volume and Customers

The business volume was $555.5 million. Customers included the U.S. Department of Energy and other federal, state and local agencies; universities; and industry sponsors. 

Awards

In FY 2002, they received one R&D 100 award, for a total of 59, also received three Federal Laboratory Consortium awards for a total 54. 

They have also won: 

5 EO Lawrence Awards 
1 Coblenz Award 
4 Discover Magazine Awards. 

Patents: In fiscal year 2002, PNNL received 32 U.S. and 58 foreign patents. Since 1965, PNNL has received a total of 1,020 U.S. and foreign patents. 

Employment: Staff employment at the end of FY 2002 was 3,824. 

Purchased Goods and Services: During 2002 fiscal year, Pacific Northwest purchased goods and services totaling more than $218 million. 

Economic Development

In 2002, Pacific Northwest's economic development programs helped create, recruit, or expand six local businesses. These businesses, which employ about 100 people, are in the areas of information technology, manufacturing, and agri-tech. 



相关新闻
生物通微信公众号
微信
新浪微博
  • 搜索
  • 国际
  • 国内
  • 人物
  • 产业
  • 热点
  • 科普
  • 急聘职位
  • 高薪职位

知名企业招聘

热点排行

    今日动态 | 人才市场 | 新技术专栏 | 中国科学人 | 云展台 | BioHot | 云讲堂直播 | 会展中心 | 特价专栏 | 技术快讯 | 免费试用

    版权所有 生物通

    Copyright© eBiotrade.com, All Rights Reserved

    联系信箱:

    粤ICP备09063491号